Does medical cannabis actually relieve insomnia?

A Cochrane review found that medical cannabis made little or no meaningful difference to sleep in studies that compared it with a placebo. The researchers said the trials were too small and too inconsistent to determine whether any specific cannabis product helps people with insomnia.

That question matters because cannabis-based products are often marketed as sleep aids. Something may make a person feel sleepy without improving how long they sleep, how rested they feel, or how well they function the next day.

The review looked at nine trials. Eight compared regulated medical cannabis with a placebo, and one compared it with amitriptyline, a drug sometimes used for sleep problems. Most of the participants had insomnia that was not linked to another medical condition.

Published in the Cochrane Database of Systematic Reviews, the analysis examined several outcomes separately. Overall, people taking cannabis did not report a meaningful advantage over placebo in sleep quality or satisfaction, and the evidence also showed little difference in sleep duration or daytime functioning.

Some studies pointed to a higher rate of mild side effects such as dry mouth and dizziness among cannabis users. However, the reviewers said their confidence in that finding was limited because only a small number of studies contributed to it.

There were also signs of a possible effect on quality of life, but the estimates were wide enough to allow for both a slight decline and a substantial improvement. As a result, the review could not determine which outcome was more likely.

The need for better insomnia treatment is also linked to research on insomnia and faster brain aging.

Because the studies used different products, it was difficult to combine the results or identify whether differences in ingredients, formulation, or dose explained the variation between trials.

Most participants were relatively young, and nearly three-quarters were women. The longest study ran for 12 weeks, which leaves only limited evidence for older adults, people with other health conditions, or anyone considering longer-term use.

The reviewers rated the certainty of the evidence as low or very low. In practical terms, that means a better-designed trial could change the estimate of benefits or harms rather than merely confirm it.

Future research could be more useful if it tests clearly defined products and follows participants long enough to show whether any benefits persist. It would also help to measure daytime alertness and the ability to carry out normal activities, since those outcomes show whether a sleep change makes a real difference.

For now, the review offers little support for viewing medical cannabis as a dependable treatment for insomnia. It also helps narrow the questions researchers need to answer before patients can get a clearer verdict on specific products.

If you are interested in this topic, please read articles about Diet can have a big impact on sleep quality, and Evening coffee may change brain’s sleep more than you realize.

For more information, please see articles about Refined carbs linked to insomnia risk in women, and Eating more fruits and vegetables can improve your sleep.

Source: Cochrane.